Skip to main content
Top
Published in: American Journal of Clinical Dermatology 3/2015

01-06-2015 | Review Article

Exogenous Ochronosis: A Comprehensive Review of the Diagnosis, Epidemiology, Causes, and Treatments

Authors: Brian J. Simmons, Robert D. Griffith, Fleta N. Bray, Leyre A. Falto-Aizpurua, Keyvan Nouri

Published in: American Journal of Clinical Dermatology | Issue 3/2015

Login to get access

Abstract

Exogenous ochronosis (EO) can be an unintended psychologically troubling condition for patients who are already being treated for longer-term hyperpigmentation disorders such as melasma. Early diagnosis is key in order that the offending agent can be stopped to prevent further disfiguring discoloration. EO can be diagnosed in the right clinical setting with the aid of dermatoscopy, which can assist in early diagnosis and may negate the need for a biopsy. Laser modalities using Q-switched lasers of longer wavelengths and combination laser dermabrasion treatments have shown the most significant results with minimal adverse events. However, further large-scale studies are needed to determine optimal treatment modalities. Although considered uncommon, the incidence of EO will likely continue to increase with the growth of immigrant populations and the use of skin-lightening agents above the FDA’s recommended over-the-counter concentrations, without the guidance of a dermatologist.
Literature
3.
go back to reference Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Q S Med. 1912;5:505–7. Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Q S Med. 1912;5:505–7.
4.
go back to reference Charlin R, Barcaui CB, Kac BK, Soares DB, Rabello-Fonseca R, Azulay-Abulafia L. Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy. Int J Dermatol. 2008;47(1):19–23.PubMed Charlin R, Barcaui CB, Kac BK, Soares DB, Rabello-Fonseca R, Azulay-Abulafia L. Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy. Int J Dermatol. 2008;47(1):19–23.PubMed
5.
go back to reference Penneys NS. Ochronosis like pigmentation from hydroquinone bleaching creams. Arch Dermatol. 1985;121(10):1239–40.PubMed Penneys NS. Ochronosis like pigmentation from hydroquinone bleaching creams. Arch Dermatol. 1985;121(10):1239–40.PubMed
6.
go back to reference Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93(6):613–22.PubMed Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93(6):613–22.PubMed
7.
go back to reference Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol. 2001;2(4):213–7.PubMed Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol. 2001;2(4):213–7.PubMed
8.
go back to reference Dogliotti M, Leibowitz M. Granulomatous ochronosis: a cosmetic-induced skin disorder in Blacks. S Afr Med J. 1979;56(19):757–60.PubMed Dogliotti M, Leibowitz M. Granulomatous ochronosis: a cosmetic-induced skin disorder in Blacks. S Afr Med J. 1979;56(19):757–60.PubMed
9.
go back to reference Jacyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestation of sarcoidosis. Am J Dermatopathol. 1995;17(1):18–22.PubMed Jacyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestation of sarcoidosis. Am J Dermatopathol. 1995;17(1):18–22.PubMed
10.
go back to reference Khunger N, Kandhari R. Dermoscopic criteria for differentiating exogenous ochronosis from melasma. Indian J Dermatol Venereol Leprol. 2013;79(6):819–21.PubMed Khunger N, Kandhari R. Dermoscopic criteria for differentiating exogenous ochronosis from melasma. Indian J Dermatol Venereol Leprol. 2013;79(6):819–21.PubMed
11.
go back to reference Liu WC, Tey HL, Lee JS, Goh BK. Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site. Singapore Med J. 2014;55(1):e1–3.PubMedCentralPubMed Liu WC, Tey HL, Lee JS, Goh BK. Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site. Singapore Med J. 2014;55(1):e1–3.PubMedCentralPubMed
12.
go back to reference Gil I, Segura S, Martinez-Escala E, Lloreta J, Puig S, Velez M, et al. Dermoscopic and reflectance confocal microscopic features of exogenous ochronosis. Arch Dermatol. 2010;146(9):1021–5.PubMed Gil I, Segura S, Martinez-Escala E, Lloreta J, Puig S, Velez M, et al. Dermoscopic and reflectance confocal microscopic features of exogenous ochronosis. Arch Dermatol. 2010;146(9):1021–5.PubMed
13.
go back to reference Cullison D, Abele DC, O’Quinn JL. Localized exogenous ochronosis. J Am Acad Dermatol. 1983;8(6):882–9.PubMed Cullison D, Abele DC, O’Quinn JL. Localized exogenous ochronosis. J Am Acad Dermatol. 1983;8(6):882–9.PubMed
14.
go back to reference Zawar V, Tan S-K. Exogenous ochronosis: a review for clinicians. Expert Rev Dermatol. 2012;7(2):171–80. Zawar V, Tan S-K. Exogenous ochronosis: a review for clinicians. Expert Rev Dermatol. 2012;7(2):171–80.
15.
go back to reference US FDA. Docket no. 78N-0065; comments PRT 4 and PRT 5. US FDA; 1998. US FDA. Docket no. 78N-0065; comments PRT 4 and PRT 5. US FDA; 1998.
17.
go back to reference Galindo GR, Mayer JA, Slymen D, Almaguer DD, Clapp E, Pichon LC, et al. Sun sensitivity in 5 US ethnoracial groups. Cutis. 2007;80(1):25–30.PubMed Galindo GR, Mayer JA, Slymen D, Almaguer DD, Clapp E, Pichon LC, et al. Sun sensitivity in 5 US ethnoracial groups. Cutis. 2007;80(1):25–30.PubMed
18.
go back to reference Werlinger KD, Guevara IL, Gonzalez CM, Rincon ET, Caetano R, Haley RW, et al. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol. 2007;143(3):424–5.PubMed Werlinger KD, Guevara IL, Gonzalez CM, Rincon ET, Caetano R, Haley RW, et al. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol. 2007;143(3):424–5.PubMed
19.
go back to reference Sivayathorn A. Melasma in orientals. Clin Drug Invest. 1995;10(Suppl 2):34. Sivayathorn A. Melasma in orientals. Clin Drug Invest. 1995;10(Suppl 2):34.
20.
go back to reference Tan SK. Exogenous ochronosis in ethnic Chinese Asians: a clinicopathological study, diagnosis and treatment. J Eur Acad Dermatol Venereol. 2011;25(7):842–50.PubMed Tan SK. Exogenous ochronosis in ethnic Chinese Asians: a clinicopathological study, diagnosis and treatment. J Eur Acad Dermatol Venereol. 2011;25(7):842–50.PubMed
21.
go back to reference Bruce S, Tschen JA, Chow D. Exogenous ochronosis resulting from quinine injections. J Am Acad Dermatol. 1986;15(2 Pt 2):357–61.PubMed Bruce S, Tschen JA, Chow D. Exogenous ochronosis resulting from quinine injections. J Am Acad Dermatol. 1986;15(2 Pt 2):357–61.PubMed
22.
go back to reference Ribas J, Schettini AP. Cavalcante Mde S. Exogenous ochronosis hydroquinone induced: a report of four cases. An Bras Dermatol. 2010;85(5):699–703.PubMed Ribas J, Schettini AP. Cavalcante Mde S. Exogenous ochronosis hydroquinone induced: a report of four cases. An Bras Dermatol. 2010;85(5):699–703.PubMed
23.
go back to reference Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol. 2008;47(4):344–53.PubMed Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol. 2008;47(4):344–53.PubMed
24.
go back to reference Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):274S–87S.PubMed Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):274S–87S.PubMed
25.
go back to reference Levitt J. The safety of hydroquinone: a dermatologist’s response to the 2006 Federal Register. J Am Acad Dermatol. 2007;57(5):854–72.PubMed Levitt J. The safety of hydroquinone: a dermatologist’s response to the 2006 Federal Register. J Am Acad Dermatol. 2007;57(5):854–72.PubMed
26.
go back to reference Jow T, Hantash BM. Hydroquinone-induced depigmentation: case report and review of the literature. Dermatitis. 2014;25(1):e1–5.CrossRefPubMed Jow T, Hantash BM. Hydroquinone-induced depigmentation: case report and review of the literature. Dermatitis. 2014;25(1):e1–5.CrossRefPubMed
27.
go back to reference Diven DG, Smith EB, Pupo RA, Lee M. Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser. J Dermatol Surg Oncol. 1990;16(11):1018–22.PubMed Diven DG, Smith EB, Pupo RA, Lee M. Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser. J Dermatol Surg Oncol. 1990;16(11):1018–22.PubMed
29.
go back to reference Schulz EJ, Summers B, Summers RS. Inappropriate treatment of cosmetic ochronosis with hydroquinone. S Afr Med J. 1988;73(1):59–60.PubMed Schulz EJ, Summers B, Summers RS. Inappropriate treatment of cosmetic ochronosis with hydroquinone. S Afr Med J. 1988;73(1):59–60.PubMed
30.
go back to reference Camarasa JG, Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis. 1994;31(1):57–8.CrossRefPubMed Camarasa JG, Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis. 1994;31(1):57–8.CrossRefPubMed
31.
go back to reference Howard KL, Furner BB. Exogenous ochronosis in a Mexican–American woman. Cutis. 1990;45(3):180–2.PubMed Howard KL, Furner BB. Exogenous ochronosis in a Mexican–American woman. Cutis. 1990;45(3):180–2.PubMed
32.
go back to reference Lawrence N, Bligard CA, Reed R, Perret WJ. Exogenous ochronosis in the United States. J Am Acad Dermatol. 1988;18(5 Pt 2):1207–11.PubMed Lawrence N, Bligard CA, Reed R, Perret WJ. Exogenous ochronosis in the United States. J Am Acad Dermatol. 1988;18(5 Pt 2):1207–11.PubMed
33.
go back to reference Martin RF, Sanchez JL, Gonzalez A, Lugo-Somolinos A, Ruiz H. Exogenous ochronosis. P R Health Sci J. 1992;11(1):23–6.PubMed Martin RF, Sanchez JL, Gonzalez A, Lugo-Somolinos A, Ruiz H. Exogenous ochronosis. P R Health Sci J. 1992;11(1):23–6.PubMed
34.
go back to reference Lang PG Jr. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion. J Am Acad Dermatol. 1988;19(5 Pt 2):942–6.PubMed Lang PG Jr. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion. J Am Acad Dermatol. 1988;19(5 Pt 2):942–6.PubMed
35.
go back to reference Hoshaw RA, Zimmerman KG, Menter A. Ochronosis like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol. 1985;121(1):105–8.PubMed Hoshaw RA, Zimmerman KG, Menter A. Ochronosis like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol. 1985;121(1):105–8.PubMed
36.
go back to reference Fisher AA. Tetracycline treatment for sarcoid-like ochronosis due to hydroquinone. Cutis. 1988;42(1):19–20.PubMed Fisher AA. Tetracycline treatment for sarcoid-like ochronosis due to hydroquinone. Cutis. 1988;42(1):19–20.PubMed
37.
go back to reference Moche MJ, Glassman SJ, Modi D, Grayson W. Cutaneous annular sarcoidosis developing on a background of exogenous ochronosis: a report of two cases and review of the literature. Clin Exp Dermatol. 2010;35(4):399–402.PubMed Moche MJ, Glassman SJ, Modi D, Grayson W. Cutaneous annular sarcoidosis developing on a background of exogenous ochronosis: a report of two cases and review of the literature. Clin Exp Dermatol. 2010;35(4):399–402.PubMed
38.
go back to reference Bellew SG, Alster TS. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser. Dermatol Surg. 2004;30(4 Pt 1):555–8.PubMed Bellew SG, Alster TS. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser. Dermatol Surg. 2004;30(4 Pt 1):555–8.PubMed
39.
go back to reference Chaptini C, Huilgol SC. Erbium-doped yttrium aluminium garnet ablative laser treatment for endogenous ochronosis. Australas J Dermatol. doi:10.1111/ajd.12199. Epub 10 Oct 2014. Chaptini C, Huilgol SC. Erbium-doped yttrium aluminium garnet ablative laser treatment for endogenous ochronosis. Australas J Dermatol. doi:10.​1111/​ajd.​12199. Epub 10 Oct 2014.
40.
go back to reference Kramer KE, Lopez A, Stefanato CM, Phillips TJ. Exogenous ochronosis. J Am Acad Dermatol. 2000;42(5 Pt 2):869–71.PubMed Kramer KE, Lopez A, Stefanato CM, Phillips TJ. Exogenous ochronosis. J Am Acad Dermatol. 2000;42(5 Pt 2):869–71.PubMed
41.
go back to reference Lee MD, Weiss E. Treatment of exogenous ochronosis with advanced fluorescence technology. Dermatol Surg. 2014;40(9):1046–8.PubMed Lee MD, Weiss E. Treatment of exogenous ochronosis with advanced fluorescence technology. Dermatol Surg. 2014;40(9):1046–8.PubMed
42.
go back to reference Tan SK. Exogenous ochronosis: successful outcome after treatment with Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2013;15(5):274–8.PubMed Tan SK. Exogenous ochronosis: successful outcome after treatment with Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2013;15(5):274–8.PubMed
43.
go back to reference Romero SA, Pereira PM, Mariano AV, Francesconi F, Francesconi VA. Use of dermoscopy for diagnosis of exogenous ochronosis. An Bras Dermatol. 2011;86(4 Suppl 1):S31–4.PubMed Romero SA, Pereira PM, Mariano AV, Francesconi F, Francesconi VA. Use of dermoscopy for diagnosis of exogenous ochronosis. An Bras Dermatol. 2011;86(4 Suppl 1):S31–4.PubMed
44.
go back to reference Kanechorn-Na-Ayuthaya P, Niumphradit N, Aunhachoke K, Nakakes A, Sittiwangkul R, Srisuttiyakorn C. Effect of combination of 1064 nm Q-switched Nd:YAG and fractional carbon dioxide lasers for treating exogenous ochronosis. J Cosmet Laser Ther. 2013;15(1):42–5.PubMed Kanechorn-Na-Ayuthaya P, Niumphradit N, Aunhachoke K, Nakakes A, Sittiwangkul R, Srisuttiyakorn C. Effect of combination of 1064 nm Q-switched Nd:YAG and fractional carbon dioxide lasers for treating exogenous ochronosis. J Cosmet Laser Ther. 2013;15(1):42–5.PubMed
Metadata
Title
Exogenous Ochronosis: A Comprehensive Review of the Diagnosis, Epidemiology, Causes, and Treatments
Authors
Brian J. Simmons
Robert D. Griffith
Fleta N. Bray
Leyre A. Falto-Aizpurua
Keyvan Nouri
Publication date
01-06-2015
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 3/2015
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-015-0126-8

Other articles of this Issue 3/2015

American Journal of Clinical Dermatology 3/2015 Go to the issue